In a new study published in Nature Medicine, researchers revealed that if China rescinds Zero-COVID policies, the country’s healthcare system will almost certainly be overwhelmed.
The highly contagious omicron variant of COVID-19 would—in the absence of existing, strict protective measures — likely kill 1.5 million people in China within a very short period.
“Our study shows that a COVID outbreak of this size will overwhelm the Chinese healthcare system, particularly the intensive care units,” Marco Ajelli says.
Marco Ajelli of the Indiana University School of Public Health-Bloomington is one of several authors of the new study.
“This does not account for other illnesses that also require beds.
If there is a bed shortage due to a sharp increase in COVID cases, people with other infections will not have access to necessary care, further increasing the number of likely deaths.”
Ajelli notes that only about half the people in China over the age of 80 are vaccinated against COVID-19.
He states that improving vaccination rates, especially in the elderly; access to antiviral therapies; masking; and other non-pharmaceutical interventions are critical to slowing the pandemic, regardless of whether China eliminates zero-COVID practices.
“As scientists, our job is to provide evidence and numbers,” he adds.
“We do not make policy recommendations or dispense advice. We provide important data so that leaders in China can make the most informed decisions possible for their country and their people.”
“It is vitally important that Chinese leaders communicate and educate their citizens regarding the value of protection against COVID,” says Dr. Philip Eskew, professor emeritus in the IU School of Medicine.
“In this paper, Dr. Ajelli and his colleagues provide a great deal of evidence to consider with respect to the wellness of the most vulnerable people in their country.”
If you care about COVID, please read studies about existing drugs that can kill COVID-19 virus, and these old vaccines can fight COVID-19 pandemic.
For more information about COVID, please see recent studies about the cause of severe inflammation in COVID-19, and results showing this drug duo may help cure COVID-19.